MRD Clinical Validation Working Group

Carol Pena, PhD

Executive Director / Distinguished Scientist, Translation Oncology - Companion Diagnostics

Merck

Co-Chairs

Dan Norton

Director, Product Management

Personalis, Inc.

Current Projects

  • Manuscript: Defining MRD testing applications and clinical study designs, with plans to focus initially on one application and produce a publication to guide adoption and optimize patient management.

Participating Organizations

Assocation for Molecular Pathology (AMP), AstraZeneca, Bio-Rad, Bristol Myers Squibb (BMS), Daiichi Sankyo, Droplet Biosciences, Eli Lilly, Exact Sciences, GRAIL, GSK, Illumina, Johnson & Johnson, Meck, Natera, Natera, NeoGenomics, Personalis, PGDx, Tempus, Thermo Fisher Scientific

Past Deliverables

Not applicable at this time.

Meetings

Working group meetings are currently on hold but will be resuming in the near future.

Special workshops and sessions:

Not applicable.